Cover Image
市場調查報告書

醫療用途的奈米技術 (奈米醫藥) 的全球市場

Nanotechnology in Medical Applications: The Global Market

出版商 BCC Research 商品編碼 229027
出版日期 內容資訊 英文 156 Pages
訂單完成後即時交付
價格
Back to Top
醫療用途的奈米技術 (奈米醫藥) 的全球市場 Nanotechnology in Medical Applications: The Global Market
出版日期: 2015年09月24日 內容資訊: 英文 156 Pages
簡介

醫療用奈米技術,即奈米醫藥的全球市場2014年達到了2483億美元。這個市場預計將更加持續成長,到2019年維持16.3%的年複合成長率 (CAGR) ,2019年市場規模達5280億美元。

本報告以醫療用奈米技術 (奈米醫藥) 的全球市場為主題,提供支撐奈米醫藥的重要技術相關詳查、奈米醫藥市場特質、結構、推動市場成長要素分析,以及各產品類型、各地區的市場分析、今後5年市場預測。並包含這個市場的主要企業相關資料、最近企業收購合併的狀況分析、詳細的企業介紹。

第1章 序論

第2章 論點

  • 奈米醫藥定義
  • 研究開發及商用化
  • 用途
  • 市場

第3章 概要

  • 關於奈米技術
  • 廣泛的奈米技術應用範圍
    • 醫療用途
    • 環境應用
    • 軍用
    • 化妝品
    • 開發中的用途
  • 奈米技術的工具
    • C60/富勒烯
    • 奈米碳管
    • 奈米粒子
    • 奈米線
    • 分子奈米技術
  • 奈米技術的風險
    • 毒性
  • 市場上的奈米技術
    • 醫療用奈米技術 - 奈米醫藥
    • 未來的可能性
    • 市場未來性

第4章 奈米醫藥

  • 奈米醫療技術的發展
  • 微脂體
  • 樹狀聚合物

第5章 奈米醫藥的治療應用

  • 癌症診斷及治療
    • 二氧化矽奈米粒子
    • 奈米級水凝膠殼
    • 藥物輸送
    • 感染控制

第6章 診斷工具

  • 工具類的實際的應用
    • 各種工具的開發企業
    • 各種的治療對象技術

第7章 未來趨勢及研究開發的可能性

  • 非侵入性奈米設備
  • 細胞外設備
  • 細胞內設備
  • 控制組織的治癒再生的奈米機器
  • 病毒消除
  • 修復化學
  • 新內臟器官及四肢
  • 基本的奈米技術研究
    • 美國
    • 歐洲
    • 日本
  • 風險要素

第8章 奈米醫藥市場

  • 推動市場成長要素
  • 主要的產品類型
    • 藥物輸送
    • 分子診斷
    • 各臨床應用市場分析
  • 地區市場分析
    • 美國
    • 日本
    • 歐洲

第9章 主要企業簡介

  • 構成全球奈米醫藥產業的主要企業

第10章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: HLC069C

REPORT HIGHLIGHTS

Global nanomedicine market was valued at $214.2 billion in 2013 and $248.3 billion in 2014. The total market is projected to grow at a compound annual growth rate (CAGR) of 16.3% from 2014 through 2019 and reach $528 billion by 2019.

This report provides:

  • An overview of the global markets for nanotechnology used in medical applications.
  • Analyses of global market trends, with data from 2012 to 2014, and projections of CAGRs through 2019.
  • A review of technologies involved, in-depth analysis of applications in practice, and evaluation of future or potential applications.
  • Information on a number of significant products in which the nano dimension has made a significant contribution to product effectiveness.
  • A look at the regulatory environment, healthcare policies, demographics, and other factors that directly affect nanotechnology used in medicine.
  • Analysis of the market's dynamics, specifically growth drivers, inhibitors, and opportunities.
  • Coverage of strategies employed by companies specializing in nanomedicine to meet the challenges of this highly competitive market.

SCOPE OF REPORT

This report discusses the implications of technology and commercial trends in the context of the current size and growth of the pharmaceutical market, both in global terms and as analyzed by selected national markets. The important technologies supporting nanomedicine are reviewed, and the nature and structure of the nanomedicine industry is discussed with profiles of the leading companies, including recent M&A activity. Five-year sales forecasts are provided for the national markets and the major therapeutic categories of products involved.

ANALYST'S CREDENTIALS

Paul Evers has been involved in analyzing pharmaceutical and medical markets for 20 years. He is the author of previous reports on the nanomedicine marketplace as well as analyses of major therapeutic categories and the pharmaceutical regulatory environment.

Table of Contents

CHAPTER 1 - INTRODUCTION

  • STUDY GOALS AND OBJECTIVES
  • REASONS FOR DOING THE STUDY
  • SCOPE OF REPORT
  • MARKET ANALYSES AND FORECASTS
  • METHODOLOGY
  • INTENDED AUDIENCE
  • INFORMATION SOURCES
  • ANALYST'S CREDENTIALS
  • RELATED BCC RESEARCH REPORTS
  • BCC RESEARCH WEBSITE
  • DISCLAIMER

CHAPTER 2 - SUMMARY

  • DEFINITION OF NANOMEDICINE
  • RESEARCH AND COMMERCIALIZATION
  • APPLICATIONS
    • DRUG DELIVERY
    • DRUGS AND THERAPY
    • IN VIVO IMAGING
    • IN VITRO DIAGNOSTICS
    • BIOMATERIALS
    • ACTIVE IMPLANTS
  • MARKET
    • SUMMARY TABLE: GLOBAL NANOMEDICINE MARKET BY THERAPEUTIC AREA, THROUGH 2019 ($ BILLIONS)
    • SUMMARY FIGURE: GLOBAL NANOMEDICINE MARKET BY THERAPEUTIC AREA, 2012-2019 ($ BILLIONS)

CHAPTER 3 - OVERVIEW

  • ABOUT NANOTECHNOLOGY
  • THE MANY USES OF NANOTECHNOLOGY
    • MEDICAL APPLICATIONS
    • ENVIRONMENTAL APPLICATIONS
    • MILITARY APPLICATIONS
    • COSMETICS
    • APPLICATIONS IN DEVELOPMENT
  • THE TOOLS OF NANOTECHNOLOGY
    • C60/FULLERENES
    • CARBON NANOTUBES
    • NANOPARTICLES
    • NANOWIRES
    • MOLECULAR NANOTECHNOLOGY
  • RISKS OF NANOTECHNOLOGY
    • POISON/TOXICITY
  • NANOTECHNOLOGY IN THE MARKETPLACE
    • MEDICAL NANOTECHNOLOGY - NANOMEDICINE
    • FUTURE POSSIBILITIES
    • MARKET POTENTIAL

CHAPTER 4 - NANOMEDICINE

  • DEVELOPMENT OF NANOMEDICAL TECHNOLOGIES
    • TABLE 1: NANOMEDICINE -- ESTMIATED TIMESCALE BY DECADE
    • TABLE 2: MAIN NANOTECHNOLOGIES AND APPLICATIONS IN MEDICINE
  • LIPOSOMES
    • TABLE 3: MARKETED LIPOSOMAL NANOPHARMACEUTICAL PRODUCTS
  • DENDRIMERS
    • NANOCRYSTALS
      • TABLE 4: MARKETED NANOCRYSTAL PHARMACEUTICAL PRODUCTS
    • MICELLES
      • TABLE 5: MARKETED PRODUCTS IN MICELLE FORM
    • FULLERENES
    • POLYMERIC NANOPARTICLES
    • NANOPARTICLE-DRUG CONJUGATES
    • LIGAND-TARGETED NANOPARTICLES
    • CERAMIC NANOPARTICLES
    • VIROSOME NANOPARTICLES

CHAPTER 5 - THERAPEUTIC USES OF NANOMEDICINE

  • CANCER DIAGNOSTICS AND THERAPY
    • SILICA NANOSPHERES
    • NANOSCALE HYDROGEL SHELLS
      • Carbon Nanoparticles
      • Photodynamic Therapy and Gold
      • Dendrimer Conjugates
      • Ligand-Targeted Emulsion Technologies
      • Linear Cyclodextrin-Containing Polymers
      • Smart Lipid-Based Nanocarriers
      • Thermotherapy Using Magnetic Nanoparticles
      • Targeted Cell Destruction
      • Nanoshells
    • DRUG DELIVERY
      • TABLE 6: MARKETED PRODUCTS WITH NANO-ENHANCED DRUG DELIVERY
      • AlphaRx
      • Aphios
      • Bind Biosciences
      • Biodelivery Sciences
      • Calando Pharmaceuticals Inc.
      • Capsulution NanoScience
      • Ceramisphere
      • CytImmune
      • Health Plus International
      • IGI Laboratories Inc.
      • Labopharm
      • MagnaMedics
      • Mebiopharm
      • Nanocopoeia
      • NanoCrystal
      • NanoMed
      • NanoCyte
      • NanoPharm
      • Nanotherapeutics
      • Nanotrope
      • pSivida
      • Selecta Biosciences
      • SoluBest
      • Transave/Insmed
    • INFECTION CONTROL
      • Silver Nanoparticles against Infection
      • Detecting Nanobacteria
      • Killing Viruses

CHAPTER 6 - DIAGNOSTIC TOOLS

  • PRACTICAL APPLICATION OF TOOLS
    • COMPANIES THAT DEVELOP THE TOOLS
      • BioCrystal/InVitrogen
      • BioForce
      • Biophage
      • CombiMatrix
      • Farfield Sensors
      • GE Healthcare BioSciences
      • Immunicon
      • MagnaMedics
      • Nanogen
      • Nanosphere
      • Qiagen
      • Sphere
      • TransGenex
      • Veredus
    • VARIOUS THERAPEUTIC TARGETS TECHNOLOGIES
      • Anthrax
      • Cholesterol
      • Artificial Retina
      • Nerve Regeneration
      • Crossing the Blood-Brain Barrier
      • Protecting Against Radiation Damage
      • Antibody Therapeutics
      • Hemostasis
      • Bone Fracture Repair
      • Dental Implant and Tissue Regeneration
      • Vaccine Adjuvant
      • Treatment of Thrombosis
      • Coatings for Stents and Other Devices

CHAPTER 7 - FUTURE TRENDS AND RESEARCH POSSIBILITIES

  • NON-INVASIVE NANODEVICES
  • EXTRACELLULAR DEVICES
  • INTRACELLULAR DEVICES
  • NANOMACHINES TO CONTROL TISSUE HEALING
  • ELIMINATING VIRUSES
  • CORRECTING CHEMISTRY
  • NEW ORGANS AND LIMBS
  • FUNDAMENTAL NANOTECHNOLOGY RESEARCH
    • UNITED STATES
      • University at Albany-SUNY
      • Cornell University
      • University of Michigan
      • Rice University
      • University of Pennsylvania
      • University of Virginia
      • University of North Carolina
      • Ohio State University
      • Northwestern University
      • University of Pittsburgh
      • Case Western Reserve University
      • University of California at Berkeley
    • EUROPE
      • TABLE 7: EUROPEAN NANOCENTRES
    • JAPAN
      • Development of Active Targeting DDS
      • Development of Novel Tissue Engineering
      • Development of New Biomaterials
  • THE RISK FACTOR

CHAPTER 8 - MARKETS FOR NANOMEDICINE

  • TABLE 8: MARKETED NANOPHARMACEUTICALS
  • TABLE 9: MARKETED NANO-IMAGING, DIAGNOSTICS AND BIOMATERIALS
  • MARKET DRIVERS
    • MARKET ESTIMATES AND FORECASTS
      • TABLE 10: GLOBAL MARKET SHARE FOR NANOTECHNOLOGY BY INDUSTRY SECTOR, 2010 (%)
    • GLOBAL NANOMEDICINE MARKET
      • TABLE 11: GLOBAL NANOMEDICINE, NANOPHARMACEUTICAL AND NANODIAGNOSTIC MARKET, THROUGH 2019 ($ BILLIONS/%)
  • MAIN PRODUCT CATEGORIES
    • DRUG DELIVERY
    • MOLECULAR DIAGNOSTICS
    • MARKET ANALYSIS BY CLINICAL APPLICATION
      • Cancer
        • TABLE 12: MAJOR MARKETED ANTICANCER NANOPHARMACEUTICAL PRODUCTS BY COMPONENT, MANUFACTURER AND SALES ($ MILLIONS)
        • TABLE 13: GLOBAL MARKET FOR CANCER NANOTHERAPEUTICS AND NANODIAGNOSTICS ($ BILLIONS)
      • CNS Disorders
        • TABLE 14: MAJOR MARKETED CNS NANOPHARMACEUTICAL PRODUCTS BY COMPONENT, MANUFATURER AND SALES ($ MILLIONS)
        • TABLE 15: GLOBAL MARKET FOR CNS NANOMEDICINES
      • Infection
        • TABLE 16: MAJOR MARKETED ANTI-INFECTIVE NANOPHARMACEUTICAL PRODUCTS BY COMPONENT, MANUFACTURER AND SALE ($ MILLIONS)
        • TABLE 17: GLOBAL MARKET FOR ANTI-INFECTIVE NANOMEDICINE, NANOTHERAPEUTICS AND NANODIAGNOSTICS ($ BILLIONS)
      • Cardiovascular and Autoimmune Disorders
        • TABLE 18: MAJOR MARKETED NANOMEDICINE PRODUCTS FOR CARDIOVASCULAR AND INFLAMMATORY DISEASES BY COMPONENT, MANUFACTURER AND SALE ($ BILLIONS)
        • TABLE 19: GLOBAL MARKET FOR CARDIOVASCULAR AND ANTI-INFLAMMATORY NANOPRODUCTS ($ BILLIONS)
  • REGIONAL MARKET ANALYSIS
    • U.S.
      • TABLE 20: U.S. NANOMEDICINE MARKET, THROUGH 2019 ($ BILLIONS/%)
    • Japan
      • TABLE 21: JAPANESE NANOMEDICINE MARKET, THROUGH 2019 ($ BILLIONS/%)
    • Europe
      • TABLE 22: GERMAN NANOMEDICINE MARKET, THROUGH 2019 ($ BILLIONS/%)
      • TABLE 23: FRENCH NANOMEDICINE MARKET, THROUGH 2019 ($ BILLIONS/%)
      • TABLE 24: UNITED KINGDOM NANOMEDICINE MARKET, THROUGH 2019 ($ BILLIONS/%)
      • TABLE 25: ITALIAN NANOMEDICINE MARKET, THROUGH 2019 ($ BILLIONS/%)
      • TABLE 26: BELGIUM AND NETHERLANDS NANOMEDICINE MARKET, THROUGH 2019 ($ BILLIONS/%)
      • TABLE 27: SPANISH NANOMEDICINE MARKET, THROUGH 2019 ($ BILLIONS/%)

CHAPTER 9 - COMPANY PROFILES

  • COMPANIES THAT COMPRISE THE GLOBALNANOMEDICINE INDUSTRY
    • ABLYNX NV
    • ABRAXIS BIOSCIENCE INC.
    • ACRYMED INC.
    • ACUSPHERE INC.
    • AMAG PHARMACEUTICALS INC.
    • ALLTRACELL
    • ANSON NANO-BIOTECHNOLOGY
    • APHIOS CORP.
      • Protein Nanoparticles
      • Polymer Nanospheres
      • Phospholipid Nanosomes
    • BIND THERAPEUTICS INC.
    • BIOCRYSTAL LTD.
    • BIOFORCE NANOSCIENCES INC.
      • The ViriChip Virus Detection Platform
    • BIO-GATE AG
      • Medical Applications
    • BIOPHAGE PHARMA INC.
      • BioPhage Products
      • Development through Collaborations:
      • Phages
    • BIOPHAN TECHNOLOGIES INC.
    • CALANDO PHARMACEUTICALS INC.
      • About CALAA-01
    • C SIXTY INC.
    • COMBIMATRIX CORP.
      • Drug Development
    • ELAN DRUG TECHNOLOGIES
    • FARFIELD SCIENTIFIC
    • GE HEALTHCARE
    • IGI LABORATORIES INC.
    • KEREOS INC.
      • KER-1001
      • KER-1002
      • KER-1003
    • KEYSTONE NANO INC.
      • NanoJackets
    • KLEINDIEK NANOTECHNIK GMBH
      • NanoWorkstation
    • LABOPHARM INC.
    • LIPLASOME PHARMA A/S
    • LUMERA CORP.
      • Product Portfolio
      • Nanocapture Microarrays
    • MAGFORCE NANOTECHNOLOGIES AG
    • MAGNAMEDICS GMBH
      • Diagnostics:
      • Efficient and Low-Cost Diagnostics
      • Multifunctional Drug Carrier
    • MICROFLUIDICS INTERNATIONAL CORP.
    • MIDATECH PHARMA PLC
    • MIV THERAPEUTICS INC.
      • Cardiovascular Heart Stents
    • MOLECULAR PROFILES (NOW JUNIPER PHARMACEUTICALS )
    • NANOBAC PHARMACEUTICALS INC.
    • NANOBIO CORP.
    • NANOBIOTIX
    • NANOCARRIER CO. LTD.
    • NANOCOPOEIA INC.
    • NANOCYTE INC.
    • NANOGEN INC.
      • Electronic Microarray
      • Instrumentation
        • Molecular Biology Workstation
        • Molecular Biology Workstation Cartridge
        • NanoChip 400 System
    • NANOLOGIX INC.
    • NANOMED PHARMACEUTICALS INC.
    • NANOMIX INC.
    • NANOSPECTRA BIOSCIENCES INC.
    • NANOSPHERE INC.
    • NANOSTRUCTURES INC.
    • NANOSYN INC.
    • NANOTHERAPEUTICS INC.
    • NANOTROPE INC.
      • Technology
    • NANOVIRICIDES INC.
      • Pipeline
    • NUCRYST PHARMACEUTICALS
    • NUTRALEASE LTD.
    • ORION INTEGRATED BIOSCIENCES INC.
      • Genomic Signatures
      • Rational Antiviral Development
      • Discovery of Malaria Invasion Pathways
    • ORTHOVITA INC.
    • PIONEER SURGICAL TECHNOLOGY
    • PSIVIDA LTD.
    • QIAGEN NV
    • SOLUBEST LTD.
    • STARPHARMA
      • Dendrimer Nanotechnology
    • TECAN GROUP LTD.
    • TRANSGENEX NANOBIOTECH INC.
      • Therapy

CHAPTER 10 - APPENDIX

  • GLOSSARY

LIST OF TABLES

  • SUMMARY TABLE: GLOBAL NANOMEDICINE MARKET BY THERAPEUTIC AREA, THROUGH 2019 ($ BILLIONS)
    • TABLE 1: NANOMEDICINE -- ESTMIATED TIMESCALE BY DECADE
    • TABLE 2: MAIN NANOTECHNOLOGIES AND APPLICATIONS IN MEDICINE
    • TABLE 3: MARKETED LIPOSOMAL NANOPHARMACEUTICAL PRODUCTS
    • TABLE 4: MARKETED NANOCRYSTAL PHARMACEUTICAL PRODUCTS
    • TABLE 5: MARKETED PRODUCTS IN MICELLE FORM
    • TABLE 6: MARKETED PRODUCTS WITH NANO-ENHANCED DRUG DELIVERY
    • TABLE 7: EUROPEAN NANOCENTRES
    • TABLE 8: MARKETED NANOPHARMACEUTICALS
    • TABLE 9: MARKETED NANO-IMAGING, DIAGNOSTICS AND BIOMATERIALS
    • TABLE 10: GLOBAL MARKET SHARE FOR NANOTECHNOLOGY BY INDUSTRY SECTOR, 2010 (%)
    • TABLE 11: GLOBAL NANOMEDICINE, NANOPHARMACEUTICAL AND NANODIAGNOSTIC MARKET, THROUGH 2019 ($ BILLIONS/%)
    • TABLE 12: MAJOR MARKETED ANTICANCER NANOPHARMACEUTICAL PRODUCTS BY COMPONENT, MANUFACTURER AND SALES ($ MILLIONS)
    • TABLE 13: GLOBAL MARKET FOR CANCER NANOTHERAPEUTICS AND NANODIAGNOSTICS ($ BILLIONS)
    • TABLE 14: MAJOR MARKETED CNS NANOPHARMACEUTICAL PRODUCTS BY COMPONENT, MANUFATURER AND SALES ($ MILLIONS)
    • TABLE 15: GLOBAL MARKET FOR CNS NANOMEDICINES
    • TABLE 16: MAJOR MARKETED ANTI-INFECTIVE NANOPHARMACEUTICAL PRODUCTS BY COMPONENT, MANUFACTURER AND SALE ($ MILLIONS)
    • TABLE 17: GLOBAL MARKET FOR ANTI-INFECTIVE NANOMEDICINE, NANOTHERAPEUTICS AND NANODIAGNOSTICS ($ BILLIONS)
    • TABLE 18: MAJOR MARKETED NANOMEDICINE PRODUCTS FOR CARDIOVASCULAR AND INFLAMMATORY DISEASES BY COMPONENT, MANUFACTURER AND SALE ($ BILLIONS)
    • TABLE 19: GLOBAL MARKET FOR CARDIOVASCULAR AND ANTI-INFLAMMATORY NANOPRODUCTS ($ BILLIONS)
    • TABLE 20: U.S. NANOMEDICINE MARKET, THROUGH 2019 ($ BILLIONS/%)
    • TABLE 21: JAPANESE NANOMEDICINE MARKET, THROUGH 2019 ($ BILLIONS/%)
    • TABLE 22: GERMAN NANOMEDICINE MARKET, THROUGH 2019 ($ BILLIONS/%)
    • TABLE 23: FRENCH NANOMEDICINE MARKET, THROUGH 2019 ($ BILLIONS/%)
    • TABLE 24: UNITED KINGDOM NANOMEDICINE MARKET, THROUGH 2019 ($ BILLIONS/%)
    • TABLE 25: ITALIAN NANOMEDICINE MARKET, THROUGH 2019 ($ BILLIONS/%)
    • TABLE 26: BELGIUM AND NETHERLANDS NANOMEDICINE MARKET, THROUGH 2019 ($ BILLIONS/%)
    • TABLE 27: SPANISH NANOMEDICINE MARKET, THROUGH 2019 ($ BILLIONS/%)

LIST OF FIGURES

  • SUMMARY FIGURE: GLOBAL NANOMEDICINE MARKET BY THERAPEUTIC AREA, 2012-2019 ($ BILLIONS)
Back to Top